- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 277/42 - Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
Patent holdings for IPC class C07D 277/42
Total number of patents in this class: 304
10-year publication summary
|
20
|
14
|
15
|
23
|
13
|
13
|
11
|
15
|
16
|
16
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 20108 |
11 |
| The Board of Trustees of the Leland Stanford Junior University | 6476 |
9 |
| Neurocrine Biosciences, Inc. | 430 |
8 |
| Novartis AG | 10721 |
7 |
| Duke University | 3090 |
7 |
| Cyteir Therapeutics, Inc. | 42 |
7 |
| Ligand Pharmaceuticals Incorporated | 171 |
6 |
| LG Chem, Ltd. | 17676 |
5 |
| ELA Pharma Ltd. | 6 |
5 |
| Sanofi | 4097 |
5 |
| PIC Therapeutics, Inc. | 12 |
5 |
| Bristol-myers Squibb Company | 4849 |
4 |
| Bayer Cropscience AG | 2014 |
4 |
| Chaperone Therapeutics, Inc | 5 |
4 |
| Dompé Farmaceutici S.p.A. | 272 |
4 |
| Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China | 184 |
4 |
| Shionogi & Co., Ltd. | 844 |
4 |
| Bayer AG | 3356 |
3 |
| Amgen Inc. | 4108 |
3 |
| The General Hospital Corporation | 4770 |
3 |
| Other owners | 196 |